Lucid-PSYCH
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Lucid-PSYCH, or LUCID-PSYCH, also known as Lucid-201, is a psychedelic hallucinogen which is under development for the treatment of major depressive disorder.[1][2][3][4][5] It is under development by Lucid Psycheceuticals.[1][2] Lucid-PSYCH's exact mechanism of action is undefined.[1][2] As of March 2023, it is in preclinical research and is progressing to phase 1 clinical trials.[1][2][6]
Other namesLUCID-PSYCH; Lucid-201
Drug classUndefined; Psychedelic; Hallucinogen
| Clinical data | |
|---|---|
| Other names | LUCID-PSYCH; Lucid-201 |
| Drug class | Undefined; Psychedelic; Hallucinogen |
